Intrarenal B cells in acute kidney allograft rejection

肾内 B 细胞在急性同种肾移植排斥反应中的作用

基本信息

  • 批准号:
    9980656
  • 负责人:
  • 金额:
    $ 79.13万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2020
  • 资助国家:
    美国
  • 起止时间:
    2020-02-15 至 2025-01-31
  • 项目状态:
    未结题

项目摘要

ABSTRACT In a seminal paper, Sarwal et al.1 reported that the presence of a B cell gene signature and dense clusters of B cells in the renal biopsies was strongly associated with glucocorticoid-resistant T cell-mediated graft rejection (TCMR) and kidney allograft loss. They proposed a hypothesis that, despite standard of care immunosuppression, infiltrating B cells play a pivotal role in a subset of acute cellular rejection of kidney allografts in the clinic. While some subsequent studies supported this hypothesis, others reported opposite outcomes. As a result, the role of intrarenal B cells in clinical TCMR is currently unclear, and an understanding of their role is urgently required to allow clinicians to rationally decide if B cell depletion might be useful for reversing steroid-resistant TCMR. We hypothesize that the identification of additional features of intrarenal B cells or of the rejecting biopsy are required to more accurately predict poor graft outcome and the need for B cell depletion to treat TCMR. These features include an understanding the specificity of intrarenal B cells and their functional properties, as well as the inflammation architecture of the biopsy. To this end, we have developed two innovative approaches to understand in situ adaptive T and B cell immunity in human biopsies from rejecting kidney allografts. First, we are able to pair the transcriptional state in single B cells with the antigenic specificity of the antibody they secrete. Sorted B cells from renal biopsies are subjected to single cell (sc) RNA-Seq, and the immunoglobulin variable regions are cloned from these same cells and expressed corresponding antibodies. Second, we have developed a novel approach to characterize the spatial architecture between different immune cell populations in human tissue and identify functional relationships2,3. Using a novel deep convolutional neural network (DCNN), coupled to a tuned neural network (TNN), we can accurately capture T cell shape change upon recognition of antigen presented by dendritic cells (DCs) in multicolor confocal micrographs. Therefore, this analytic pipeline (Cell Distance Mapping, CDM) can identify and quantify antigen presentation in fixed tissue samples from both mice and humans. We will use CDM to study T cell interactions with B cells or dendritic cells (DCs) in rejecting kidney biopsies. Third, we developed a mouse model of kidney transplantation to address mechanistic questions raised by observations made from the human renal biopsies. We will apply these three approaches to test our project hypothesis in two Aims: Aim 1. Test the hypothesis that the different transcriptional and functional states of intrarenal B cells during rejection are associated with B cell receptor (BCR) specificity and rejection type. Aim 2: Test the hypothesis that the type of cellular rejection (T cell mediated rejection vs. mixed T cell- and antibody-mediated rejection) is defined by characteristic in situ cellular interactions between T cells and B cells or DCs that are amenable to specific therapeutic intervention.
摘要 在一篇开创性的论文中,Sarwal等1报道了B细胞基因特征和密集簇的存在, 肾活检组织中B细胞的数量与糖皮质激素抵抗性T细胞介导的移植物 排斥反应(TCMR)和肾移植物丢失。他们提出了一个假设,尽管标准的护理, 免疫抑制、浸润性B细胞在肾急性细胞排斥反应中起关键作用 临床上的异体移植虽然随后的一些研究支持这一假设,但另一些研究则相反。 结果。因此,肾内B细胞在临床TCMR中的作用目前尚不清楚, 迫切需要了解它们的作用,以使临床医生能够合理地决定B细胞耗竭是否对 逆转类固醇耐药TCMR。我们假设,肾内B的其他特征的识别 细胞或排斥活检的结果,以更准确地预测不良移植物的结果和B的需要 细胞耗竭以治疗TCMR。这些特征包括了解肾内B细胞的特异性, 它们的功能特性,以及活检的炎症结构。为此我们 开发了两种创新方法来了解人体活检中的原位适应性T和B细胞免疫 移植肾排斥反应首先,我们能够将单个B细胞中的转录状态与 它们分泌的抗体的抗原特异性。对来自肾活检的分选的B细胞进行单细胞免疫分析。 (sc)从这些相同的细胞克隆并表达免疫球蛋白可变区 相应的抗体。其次,我们开发了一种新的方法来描述空间 人体组织中不同免疫细胞群体之间的架构并识别功能关系2,3。 使用一种新的深度卷积神经网络(DCNN),再加上一个调谐神经网络(TNN),我们可以 在树突状细胞(DC)识别抗原后,准确捕获T细胞形状的变化, 共聚焦显微照片。因此,该分析管道(单元距离映射,CDM)可以识别 并定量来自小鼠和人的固定组织样品中的抗原呈递。我们将使用CDM 研究T细胞与B细胞或树突状细胞(DC)在排斥肾活检中的相互作用。第三,我们开发了一个 小鼠肾移植模型,以解决由以下观察提出的机制问题: 人类肾脏活检我们将应用这三种方法来测试我们的项目假设在两个目标: 目标1.检验肾内B细胞的不同转录和功能状态在肾移植过程中的假设。 排斥与B细胞受体(BCR)特异性和排斥类型有关。 目的2:检验细胞排斥的类型(T细胞介导的排斥与混合T细胞-和 抗体介导的排斥)由T细胞和B细胞之间的特征性原位细胞相互作用定义 或适合于特定治疗干预的DC。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Anita S Chong其他文献

Anita S Chong的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Anita S Chong', 18)}}的其他基金

Intrarenal B cells in acute kidney allograft rejection
肾内 B 细胞在急性同种肾移植排斥反应中的作用
  • 批准号:
    10543172
  • 财政年份:
    2020
  • 资助金额:
    $ 79.13万
  • 项目类别:
Intrarenal B cells in acute kidney allograft rejection
肾内 B 细胞在急性同种肾移植排斥反应中的作用
  • 批准号:
    10329990
  • 财政年份:
    2020
  • 资助金额:
    $ 79.13万
  • 项目类别:
Deconstructing B cell transplantation tolerance
解构B细胞移植耐受性
  • 批准号:
    10455472
  • 财政年份:
    2019
  • 资助金额:
    $ 79.13万
  • 项目类别:
Deconstructing B cell transplantation tolerance
解构B细胞移植耐受性
  • 批准号:
    10216969
  • 财政年份:
    2019
  • 资助金额:
    $ 79.13万
  • 项目类别:
Supramolecular nanofiber vaccines
超分子纳米纤维疫苗
  • 批准号:
    8911035
  • 财政年份:
    2015
  • 资助金额:
    $ 79.13万
  • 项目类别:
Supramolecular nanofiber vaccines
超分子纳米纤维疫苗
  • 批准号:
    9402045
  • 财政年份:
    2015
  • 资助金额:
    $ 79.13万
  • 项目类别:
Supramolecular nanofiber vaccines
超分子纳米纤维疫苗
  • 批准号:
    9217567
  • 财政年份:
    2015
  • 资助金额:
    $ 79.13万
  • 项目类别:
Administrative Core
行政核心
  • 批准号:
    8512663
  • 财政年份:
    2013
  • 资助金额:
    $ 79.13万
  • 项目类别:
Impact of Infections on the Stability of Established Tolerance
感染对既定耐受稳定性的影响
  • 批准号:
    8512661
  • 财政年份:
    2013
  • 资助金额:
    $ 79.13万
  • 项目类别:
Infections and The Stability of Transplantation Tolerance
感染和移植耐受的稳定性
  • 批准号:
    8512659
  • 财政年份:
    2012
  • 资助金额:
    $ 79.13万
  • 项目类别:

相似海外基金

Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
  • 批准号:
    MR/X02329X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 79.13万
  • 项目类别:
    Fellowship
Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
  • 批准号:
    MR/Y009568/1
  • 财政年份:
    2024
  • 资助金额:
    $ 79.13万
  • 项目类别:
    Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
  • 批准号:
    10090332
  • 财政年份:
    2024
  • 资助金额:
    $ 79.13万
  • 项目类别:
    Collaborative R&D
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
  • 批准号:
    MR/X021882/1
  • 财政年份:
    2024
  • 资助金额:
    $ 79.13万
  • 项目类别:
    Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
  • 批准号:
    2312694
  • 财政年份:
    2024
  • 资助金额:
    $ 79.13万
  • 项目类别:
    Standard Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
  • 批准号:
    EP/Y003527/1
  • 财政年份:
    2024
  • 资助金额:
    $ 79.13万
  • 项目类别:
    Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
  • 批准号:
    EP/Y030338/1
  • 财政年份:
    2024
  • 资助金额:
    $ 79.13万
  • 项目类别:
    Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
  • 批准号:
    MR/X029557/1
  • 财政年份:
    2024
  • 资助金额:
    $ 79.13万
  • 项目类别:
    Research Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
  • 批准号:
    24K19395
  • 财政年份:
    2024
  • 资助金额:
    $ 79.13万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Collaborative Research: Changes and Impact of Right Ventricle Viscoelasticity Under Acute Stress and Chronic Pulmonary Hypertension
合作研究:急性应激和慢性肺动脉高压下右心室粘弹性的变化和影响
  • 批准号:
    2244994
  • 财政年份:
    2023
  • 资助金额:
    $ 79.13万
  • 项目类别:
    Standard Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了